SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001493152-19-017440
Filing Date
2019-11-14
Accepted
2019-11-14 16:01:40
Documents
60
Period of Report
2019-09-30

Document Format Files

Seq Description Document Type Size
1 form10-q.htm 10-Q 826686
2 ex31.htm EX-31 35009
3 ex32.htm EX-32 9077
  Complete submission text file 0001493152-19-017440.txt   4045803

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE FILE age-20190930.xml EX-101.INS 744441
5 XBRL SCHEMA FILE age-20190930.xsd EX-101.SCH 42768
6 XBRL CALCULATION FILE age-20190930_cal.xml EX-101.CAL 65157
7 XBRL DEFINITION FILE age-20190930_def.xml EX-101.DEF 169986
8 XBRL LABEL FILE age-20190930_lab.xml EX-101.LAB 298641
9 XBRL PRESENTATION FILE age-20190930_pre.xml EX-101.PRE 250828
Mailing Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501
Business Address 965 ATLANTIC AVENUE SUITE 101 ALAMEDA CA 94501 510-671-8370
AgeX Therapeutics, Inc. (Filer) CIK: 0001708599 (see all company filings)

IRS No.: 821436829 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-38519 | Film No.: 191219862
SIC: 2834 Pharmaceutical Preparations